Device User Fee Reauthorization Imperative By August, HHS Official Says
This article was originally published in The Gray Sheet
FDA will begin laying off staff if Congress does not pass a medical device user fee reauthorization bill by August, according to an administration official
You may also be interested in...
Legislation reauthorizing the medical device user fee program passed the Senate May 9. Action is now needed in the House to prevent the program from expiring on September 30
Despite disappointment in its Phase III study, Roche is preparing a new trial of the antisense therapy in patients with a lower disease burden.
The German biotech inks its fifth metabolic disease collaboration as it teams up with US major Eli Lilly to develop kidney disease and diabetes assets.